Marlene Modi

2.9k total citations · 1 hit paper
18 papers, 2.3k citations indexed

About

Marlene Modi is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Marlene Modi has authored 18 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Hepatology and 4 papers in Rheumatology. Recurrent topics in Marlene Modi's work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Marlene Modi is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and Systemic Lupus Erythematosus Research (4 papers). Marlene Modi collaborates with scholars based in United States, Switzerland and Germany. Marlene Modi's co-authors include Nancy Martin, J. Milton Harris, Jung‐Hun Lee, Eva Herrmann, K. Rajender Reddy, Simon C.J. Pedder, Stefan Zeuzem, George Marinos, Pascal Bailon and Wen Pan and has published in prestigious journals such as Gastroenterology, Hepatology and Advanced Drug Delivery Reviews.

In The Last Decade

Marlene Modi

18 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pegylation

2001 724 citations J. Milton Harris, Nancy Martin et al. Clinical Pharmacokinetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marlene Modi United States	13	745	668	632	346	324	18	2.3k
Zu‐Hua Gao Canada	32	1.2k 1.6×	423 0.6×	359 0.6×	138 0.4×	130 0.4×	143	3.3k
Masakazu Ueda Japan	34	1.3k 1.8×	358 0.5×	194 0.3×	284 0.8×	160 0.5×	124	3.6k
Peter McCourt Norway	28	972 1.3×	566 0.8×	569 0.9×	46 0.1×	100 0.3×	66	2.7k
E. Wisse Belgium	22	864 1.2×	468 0.7×	624 1.0×	66 0.2×	112 0.3×	41	2.4k
Sonya A. MacParland Canada	16	672 0.9×	574 0.9×	671 1.1×	70 0.2×	409 1.3×	51	2.2k
Mark A. Burton Australia	23	835 1.1×	178 0.3×	860 1.4×	497 1.4×	232 0.7×	65	2.8k
Kun Cheng United States	36	2.5k 3.3×	395 0.6×	419 0.7×	431 1.2×	698 2.2×	102	4.4k
Gerrit Wolters‐Eisfeld Netherlands	31	819 1.1×	267 0.4×	153 0.2×	104 0.3×	91 0.3×	105	2.8k
Jin Zhu China	30	1.3k 1.7×	191 0.3×	137 0.2×	264 0.8×	148 0.5×	132	2.9k
Thilo Spruß Germany	31	1.6k 2.1×	240 0.4×	194 0.3×	64 0.2×	276 0.9×	80	3.7k

Countries citing papers authored by Marlene Modi

Since Specialization

Citations

This map shows the geographic impact of Marlene Modi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlene Modi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlene Modi more than expected).

Fields of papers citing papers by Marlene Modi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlene Modi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlene Modi. The network helps show where Marlene Modi may publish in the future.

Co-authorship network of co-authors of Marlene Modi

This figure shows the co-authorship network connecting the top 25 collaborators of Marlene Modi. A scholar is included among the top collaborators of Marlene Modi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlene Modi. Marlene Modi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Bastia, Elena, Nicoletta Almirante, Michael V.W. Bergamini, et al.. (2019). Nonclinical development of NCX 470, a novel nitric oxide (NO)-donating,IOP lowering prostaglandin analog for glaucoma and ocular hypertension. 60(9). 3806–3806. 1 indexed citations

Foy, Jeffrey W.-D., Kay D. Rittenhouse, Marlene Modi, & Manju Patel. (2007). Local Tolerance and Systemic Safety of Pegaptanib Sodium in the Dog and Rabbit. Journal of Ocular Pharmacology and Therapeutics. 23(5). 452–466. 41 indexed citations

Apte, Rajendra S., et al.. (2007). Pegaptanib 1-Year Systemic Safety Results from a Safety–Pharmacokinetic Trial in Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology. 114(9). 1702–1712.e2. 82 indexed citations

Modi, Marlene, et al.. (2005). Peginterferon alfa-2a (40KD): A Potent Long-Acting Form of Interferon alfa-2a for the Treatment of Hepatitis C. Kluwer Academic Publishers eBooks. 519. 59–67. 4 indexed citations

Herrmann, Eva, Jung‐Hun Lee, George Marinos, Marlene Modi, & Stefan Zeuzem. (2003). Effect of Ribavirin on Hepatitis C Viral Kinetics in Patients Treated With Pegylated Interferon. Hepatology. 37(6). 1351–1358. 204 indexed citations

Reddy, K. Rajender, Marlene Modi, & Simon C.J. Pedder. (2002). Use of peginterferon alfa-2a (40 KD) (Pegasys®) for the treatment of hepatitis C. Advanced Drug Delivery Reviews. 54(4). 571–586. 179 indexed citations

Harris, J. Milton, Nancy Martin, & Marlene Modi. (2001). Pegylation. Clinical Pharmacokinetics. 40(7). 539–551. 724 indexed citations breakdown →

Zeuzem, Stefan, Jung‐Hun Lee, Eva Herrmann, et al.. (2001). Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon α2a. Gastroenterology. 120(6). 1438–1447. 221 indexed citations

Modi, Marlene, Nancy Martin, Jenny Heathcote, Keith Nieforth, & Stefan Zeuzem. (2001). Peginterferon alfa-2a (40 kDa) monotherapy: a novel agent for chronic hepatitis C therapy. Expert Opinion on Investigational Drugs. 10(12). 2201–2213. 26 indexed citations

10.

Abraham, Edward, Jorge Garbino, Thomas Butler, et al.. (2001). Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Critical Care Medicine. 29(3). 503–510. 218 indexed citations

11.

Bailon, Pascal, Alicia V. Palleroni, Cheryl Spence, et al.. (2001). Rational Design of a Potent, Long-Lasting Form of Interferon: A 40 kDa Branched Polyethylene Glycol-Conjugated Interferon α-2a for the Treatment of Hepatitis C. Bioconjugate Chemistry. 12(2). 195–202. 483 indexed citations

12.

Jorga, Karin, et al.. (2000). Effect of Tolcapone on the Haemodynamic Effects and Tolerability of Desipramine. European Neurology. 44(2). 94–103. 2 indexed citations

13.

Ädelroth, E, et al.. (1997). Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4–receptor antagonist cinalukast. Journal of Allergy and Clinical Immunology. 99(2). 210–215. 47 indexed citations

14.

Adams, José A., et al.. (1997). The Pharmacokinetics of Bumetanide in the Newborn Infant. Neonatology. 72(5). 265–272. 26 indexed citations

15.

Modi, Marlene, et al.. (1995). Interspecies scaling of a thienodiazepine platelet-activating factor receptor antagonist.. Drug Metabolism and Disposition. 23(7). 776–778. 2 indexed citations

16.

Steinberg, Gary K., Nariman Panahian, Miguel A. Pérez‐Pinzón, et al.. (1995). Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia. Neurobiology of Disease. 2(2). 109–118. 22 indexed citations

17.

Evans, Rebecca M., et al.. (1991). Dose-dependent and time-dependent pharmacokinetics in the dog after intravenous administration of dextrorphan.. Drug Metabolism and Disposition. 19(1). 245–250. 3 indexed citations

18.

Modi, Marlene, James M. Hassett, & David Lalka. (1988). Influence of posture on hepatic perfusion and the presystemic biotransformation of propranolol: simulation of the food effect. Clinical Pharmacology & Therapeutics. 44(3). 268–274. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact